Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Sarcoma 1Myeloid 1Lymphoid 1

Conditions

Gliosarcoma 3Glioblastoma 3Glioma 2Sarcoma, Myeloid 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Osteosarcoma 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Myelodysplastic Syndromes 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 4fludarabine phosphate 3fludarabine 2Whole-Body Irradiation 2Tacrolimus 2Mycophenolic Acid 2Cytarabine 2Azacitidine 2venetoclax 1thymoglobulin 1tazemetostat 1romidepsin 1quizartinib 1plerixafor 1glucarpidase 1cc-486 1capmatinib 1aldesleukin 1Zoledronic Acid 1Vincristine 1Transplantation 1Thiotepa 1Spironolactone 1Rituximab 1Rifampin 1Pravastatin 1Polymerase Chain Reaction 1Palliative Care 1Methotrexate 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × plerixafor × Sarcoma × Clear all
NCT01621477 2017-02-20

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

St. Jude Children's Research Hospital

Phase 2 Terminated
34 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡